[1]褚春沐.丁苯酞序贯治疗对急性进展性脑梗死患者神经功能、炎症因子及Hcy、NSE的影响[J].医学信息,2022,35(17):129-131.[doi:10.3969/j.issn.1006-1959.2022.17.035]
　CHU Chun-mu.Effect of Butylphthalide Sequential Therapy on Neurological Function, Inflammatory Factors, Hcy and NSE in Patients with Acute Progressive Cerebral Infarction[J].Journal of Medical Information,2022,35(17):129-131.[doi:10.3969/j.issn.1006-1959.2022.17.035]
点击复制

丁苯酞序贯治疗对急性进展性脑梗死患者神经功能、炎症因子及Hcy、NSE的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年17期
页码:
129-131
栏目:
药物与临床
出版日期:
2022-09-01

文章信息/Info

Title:
Effect of Butylphthalide Sequential Therapy on Neurological Function, Inflammatory Factors, Hcy and NSE in Patients with Acute Progressive Cerebral Infarction
文章编号:
1006-1959（2022）17-0129-03
作者:
褚春沐
（佳木斯市中心医院神经内科，黑龙江 佳木斯 154002）
Author(s):
CHU Chun-mu
(Department of Neurology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
关键词:
丁苯酞; 序贯治疗; 急性进展性脑梗死; 神经功能; 炎症因子
Keywords:
Butylphthalide; Sequential therapy; Acute progressive cerebral infarction; Neurological function; Inflammatory factors
分类号:
R743.33
DOI:
10.3969/j.issn.1006-1959.2022.17.035
文献标志码:
A
摘要:
目的 研究丁苯酞序贯治疗对急性进展性脑梗死患者神经功能、炎症因子及Hcy、NSE的影响。方法 选取2020年7月-2021年7月在我院诊治的90例急性进展性脑梗死患者为研究对象，采用随机数字表法分为对照组和观察组，各45例。对照组采用抗血小板常规治疗，观察组在对照组基础上采用丁苯酞序贯治疗，比较两组临床总有效率、神经功能缺损评分、炎症因子水平、同型半胱氨酸（Hcy）、神经元特异性烯醇化酶（NSE）以及不良反应发生情况。结果 观察组治疗总有效率为95.56%，高于对照组的84.44%（P＜0.05）；两组神经功能缺损评分均低于治疗前，且观察组低于对照组（P＜0.05）；两组超敏-C反应蛋白（hs-CRP）、白介素-6（IL-6）水平均低于治疗前，且观察组低于对照组（P＜0.05）；两组Hcy、NSE均低于治疗前，且观察组低于对照组（P＜0.05）；两组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论 丁苯酞序贯治疗急性进展性脑梗死效果确切，治疗总有效率高，可降低神经功能缺损评分、炎症因子水平、Hcy、NSE，且不会增加不良反应，是一种安全、有效的治疗方法。
Abstract:
Objective To study the effect of butylphthalide sequential therapy on neurological function, inflammatory factors, Hcy and NSE in patients with acute progressive cerebral infarction.Methods A total of 90 patients with acute progressive cerebral infarction diagnosed and treated in our hospital from July 2020 to July 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 45 cases in each group. The control group was treated with conventional antiplatelet therapy, and the observation group was treated with butylphthalide sequential therapy on the basis of the control group. The clinical total effective rate, neurological deficit score, inflammatory factor level, homocysteine (Hcy), neuron-specific enolase (NSE) and adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 95.56%, which was higher than 84.44% in the control group (P<0.05). The neurological deficit scores of the two groups were lower than those before treatment, and those in the observation group were lower than those in the control group (P<0.05). The levels of hypersensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6) in the two groups were lower than those before treatment, and the observation group was lower than the control group (P<0.05). The levels of Hcy and NSE in the two groups were lower than those before treatment, and those in the observation group was lower than those in the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion Butylphthalide sequential therapy is effective in the treatment of acute progressive cerebral infarction, the total effective rate is high, and can reduce neurological deficit score, inflammatory factor level, Hcy and NSE, and will not increase adverse reactions. It is a safe and effective treatment method.

参考文献/References:

[1]葛晓航,刘乐喜,赵秀秀.丁苯酞对急性脑梗死患者神经功能及脑血管储备能力的影响[J].中国实用神经疾病杂志,2016,19(3):109-110．[2]贾汉伟,蒋雷.丁苯酞氯化钠注射液治疗进展性脑梗死疗效观察[J].中国实用神经疾病杂志,2016,19(22):48-49．[3]Zhao M,Zhang L,Wang Z,et al.Dynamic analysis of blood pressurechanges in progressive cerebral infarction[J].Int Health,2016,7(4):293-297．[4]胡海荣,潘亮发,郭伟伟.低分子肝素钙与丁苯酞对急性进展性脑梗死患者的疗效及其对炎性因子和血管内皮功能的影响[J].抗感染药学,2017,14(2):395-397.[5]宋晓明,郑珍婕,苏立静,等.丁苯酞序贯治疗对急性进展性脑梗死患者神经功能、炎症因子及 Hcy、NSE 的影响[J].中华全科医学,2017,15(3):434-436．[6]Zang RS,Zhang H,Xu Y,et al.Serum C-reactive protein,fibrinogenand D-dimer in patients with progressive cerebral infarction[J].Transl Neurosci,2016,7(1):84-88．[7]刘小军,吴开毅,刘南午,等.巴曲酶注射液联合丁苯酞注射液治疗急性进展性脑梗死的临床研究[J].中国临床药理学杂志,2018,34(15):17-20.[8]薛永俊.丁苯酞注射液联合依达拉奉对急性脑梗死患者神经功能的影响[J].临床合理用药杂志,2020,13(5):57-58.[9]王御林,钟纯正,郭春宣,等.丁苯酞氯化钠注射液联合奥扎格雷钠注射液治疗急性进展性脑梗死的临床研究[J].中国医院用药评价与分析,2020,20(4):428-431.[10]王玉鹏,王丽英,张轻霞.丁苯酞软胶囊联合依达拉奉注射液治疗进展性脑梗死的疗效观察[J].临床合理用药杂志,2017,10(17):31-32.[11]胡岩芳,王建民,刘科,等.急性进展性脑梗死应用 依达拉奉联合丁苯酞注射液及丁苯酞胶囊序贯治疗的疗效[J].中国临床研究,2018,31(3):393-396.[12]宋晓慧,李惠敏.丁苯酞氯化钠注射液对进展性脑梗 死患者双抗血小板疗效及神经缺损功能恢复的影响[J].罕少疾病杂志,2017,24(1):9-10.[13]陶林,马婷.丁苯酞注射液、胶囊序贯疗法辅治急性进展性脑梗死的疗效及其对神经功能的影响[J].医学信息,2019,32(18):135-137．[14]范道丰,胡职舟,潘丽英,等.丁苯酞序贯疗法对急性脑 梗死的临床疗效及血清白细胞介素-6、金属基质蛋白酶-2、金属基质蛋白酶-9的影响[J].吉林医学,2019,40(8):1699-1702．[15]郑颖炜.丁苯酞序贯疗法联合双联抗血小板治疗老年 急性脑梗死的临床疗效及其对血浆巯基丙酮酸硫基转移酶、β淀粉样蛋白42水平的影响研究[J].实用心脑肺血管病杂志,2017,25(9):33-36,46.[16]蒋国红,徐祖才,王长明.丁苯酞序贯疗法联合早期神经 康复治疗急性脑梗死临床研究[J].癫痫与神经电生理学杂志,2018,27(5):282-284,290．[17]冀新红.丁苯酞治疗非痴呆性血管性认知功能障碍30例临床观察[J].陕西医学杂志,2018,47(1):117-119．[18]卢方理,周经霞,贝宁.阿替普酶联合丁苯酞治疗急性脑梗死的效果及机制分析[J].山东医药,2020,60(2):77-79.

相似文献/References:

[1]李 丹.丁苯酞联合银杏达莫治疗急性脑梗死的疗效[J].医学信息,2020,33(05):161.[doi:10.3969/j.issn.1006-1959.2020.05.053]
　LI Dan.Efficacy of Butylphthalide Combined with Ginkgo Leaf Extract and Dipyridamole in the Treatment of Acute Cerebral Infarction[J].Journal of Medical Information,2020,33(17):161.[doi:10.3969/j.issn.1006-1959.2020.05.053]
[2]赵林珊,刘 兴,耿 瑜.丁苯酞注射液治疗急性前循环脑梗死的效果[J].医学信息,2020,33(13):113.[doi:10.3969/j.issn.1006-1959.2020.13.032]
　ZHAO Lin-shan,LIU Xing,GENG Yu.Effect of Butylphthalide Injection on Acute Anterior Circulation Cerebral Infarction[J].Journal of Medical Information,2020,33(17):113.[doi:10.3969/j.issn.1006-1959.2020.13.032]
[3]黄绮娟,陈劲新,黄小良.丁苯酞联合依达拉奉治疗非致残性脑梗死的效果及对患者神经功能的影响[J].医学信息,2021,34(08):144.[doi:10.3969/j.issn.1006-1959.2021.08.038]
　HUANG Qi-juan,CHEN Jin-xin,HUANG Xiao-liang.The Effect of Butylphthalide Combined with Edaravone in the Treatment of Non-disabling Cerebral Infarction and Its Influence on Patients’ Neurological Function[J].Journal of Medical Information,2021,34(17):144.[doi:10.3969/j.issn.1006-1959.2021.08.038]
[4]贾红芳,董林森,李文芳.尤瑞克林联合丁苯酞治疗急性缺血性脑卒中的效果及对神经功能的影响[J].医学信息,2021,34(22):139.[doi:10.3969/j.issn.1006-1959.2021.22.043]
　JIA Hong-fang,DONG Lin-sen,LI Wen-fang.Effect of Urinary Kallidinogenase Combined with Butylphthalide on Acute Ischemic Stroke and its Effect on Neurological Function[J].Journal of Medical Information,2021,34(17):139.[doi:10.3969/j.issn.1006-1959.2021.22.043]
[5]娄永忠,王 涛,郭筱菲,等.丁苯酞对缺血性脑卒中患者神经功能缺损程度影响的临床研究[J].医学信息,2022,35(04):115.[doi:10.3969/j.issn.1006-1959.2022.04.028]
　LOU Yong-zhong,WANG Tao,GUO Xiao-fei,et al.Clinical Study on the Effect of Butylphthalide on Neurological Deficits in Patients with Ischemic Stroke[J].Journal of Medical Information,2022,35(17):115.[doi:10.3969/j.issn.1006-1959.2022.04.028]
[6]孙 勇.多奈哌齐联合丁苯酞治疗血管性痴呆的临床疗效及对神经功能恢复的影响[J].医学信息,2023,36(23):77.[doi:10.3969/j.issn.1006-1959.2023.23.019]
　SUN Yong.Clinical Efficacy of Donepezil Combined with Butylphthalide in the Treatment of Vascular Dementia and its Effect on the Recovery of Neurological Function[J].Journal of Medical Information,2023,36(17):77.[doi:10.3969/j.issn.1006-1959.2023.23.019]

更新日期/Last Update: 1900-01-01